Finch Therapeutics Group, Inc. (FNCH) DCF Valuation

Finch Therapeutics Group, Inc. (FNCH) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Finch Therapeutics Group, Inc. (FNCH) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate the financial outlook of Finch Therapeutics Group, Inc. (FNCH) with expert precision! This (FNCH) DCF Calculator provides pre-filled financial data while offering you the flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your predictions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 10.2 7.7 18.5 .9 .1 .1 .1 .0 .0 .0
Revenue Growth, % 0 -23.98 140.08 -95.35 -87.57 -26.73 -26.73 -26.73 -26.73 -26.73
EBITDA -20.7 -38.6 -57.7 -82.7 -32.5 -.1 -.1 .0 .0 .0
EBITDA, % -203.47 -500.66 -311.27 -9603.6 -30357.01 -100 -100 -100 -100 -100
Depreciation .5 .8 2.3 5.5 1.5 .0 .0 .0 .0 .0
Depreciation, % 4.75 10.23 12.42 639.61 1420.56 45.48 45.48 45.48 45.48 45.48
EBIT -21.1 -39.4 -60.0 -88.2 -34.0 -.1 -.1 .0 .0 .0
EBIT, % -208.21 -510.9 -323.68 -10243.21 -31777.57 -100 -100 -100 -100 -100
Total Cash 42.2 99.7 133.5 71.0 25.1 .1 .1 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 4.7 1.1 .5 .1 .0
Account Receivables, % 46.74 14.19 2.67 16.72 0
Inventories .0 .0 -9.1 -3.5 .0 .0 .0 .0 .0 .0
Inventories, % 0.000009848336 0 -48.94 -408.01 0 -29.79 -29.79 -29.79 -29.79 -29.79
Accounts Payable .7 2.6 3.7 1.1 .1 .0 .0 .0 .0 .0
Accounts Payable, % 6.45 33.96 20.17 127.41 131.78 52.11 52.11 52.11 52.11 52.11
Capital Expenditure -1.0 -2.6 -16.0 -2.2 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -9.9 -34.11 -86.25 -253.43 0 -46.05 -46.05 -46.05 -46.05 -46.05
Tax Rate, % 4.42 4.42 4.42 4.42 4.42 4.42 4.42 4.42 4.42 4.42
EBITAT -20.8 -39.3 -57.6 -87.5 -32.5 -.1 -.1 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -25.4 -35.6 -60.5 -92.0 -35.3 -.2 -.1 -.1 .0 .0
WACC, % 6.71 6.75 6.65 6.74 6.64 6.7 6.7 6.7 6.7 6.7
PV UFCF
SUM PV UFCF -.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value -1
Present Terminal Value 0
Enterprise Value -1
Net Debt 5
Equity Value -6
Diluted Shares Outstanding, MM 2
Equity Value Per Share -3.58

What You Will Get

  • Real Finch Therapeutics Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Finch Therapeutics' fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.

Key Features

  • Comprehensive Financial Data: Access accurate pre-loaded historical data and future projections specific to Finch Therapeutics Group, Inc. (FNCH).
  • Tailored Forecast Assumptions: Modify yellow-highlighted cells such as WACC, growth rates, and profit margins to fit your analysis.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow evaluations.
  • Interactive Dashboard: User-friendly charts and summaries to effectively visualize your valuation outcomes.
  • Designed for All Users: A straightforward, intuitive layout suitable for investors, CFOs, and consultants alike.

How It Works

  • Download: Obtain the ready-to-use Excel file featuring Finch Therapeutics Group, Inc. (FNCH) financial data.
  • Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to suit your analysis.
  • Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation insights to inform your investment choices.

Why Choose This Calculator?

  • Designed for Experts: A specialized tool utilized by researchers, financial analysts, and biopharma consultants.
  • Comprehensive Data: Finch Therapeutics' historical and projected financials preloaded for precise analysis.
  • Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Transparent Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth calculation process.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive valuation models for assessing Finch Therapeutics Group, Inc. (FNCH) investments.
  • Biotech Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Finch Therapeutics Group, Inc. (FNCH).
  • Students and Educators: Utilize real-time data to practice and teach financial modeling in the biotech sector.
  • Life Sciences Enthusiasts: Gain insights into how biotech companies like Finch Therapeutics Group, Inc. (FNCH) are valued in the market.

What the Template Contains

  • Historical Data: Includes Finch Therapeutics Group’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Finch Therapeutics Group’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Finch Therapeutics Group’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.